Decadron

(dexamethasone)

ApprovedSmall molecule

Dexamethasone is a steroid medication used to reduce inflammation and suppress the immune system in conditions like arthritis, allergies, asthma, and certain cancers. It's also used to reduce swelling in the brain and to help manage severe COVID-19 symptoms.[2] Decadron is currently approved and in use across 402 indications[4].[1]

Decadron is one of 2939 small molecule programs targeting Total Knee Arthroplasty. It is currently in Approved.

402

Indications

2,317

Total Trials

Active Trials

2,938

Competitors

FDA Applications

NDA/BLA/ANDA regulatory filings

Patents

Pipeline

Status by Indication[4][1]

Indication

Total Knee ArthroplastyCompleted

LeukemiaCompleted

AsthmaCompleted

AmyloidosisTerminated

PlasmacytomaTerminated

PulpitisUnknown status

Ovarian CancerRecruiting

Immune ThrombocytopeniaCompleted

Hearing LossNot yet recruiting

Acute Lymphoblastic LeukemiaUnknown status

Total Knee ArthroplastyApproved

Completed

LeukemiaPhase 3

Completed

AsthmaApproved

Completed

AmyloidosisPhase 3

Terminated

PlasmacytomaPhase 3

Terminated

PulpitisPhase 1

Unknown status

Ovarian CancerApproved

Recruiting

Immune ThrombocytopeniaApproved

Completed

Hearing LossApproved

Not yet recruiting

Acute Lymphoblastic LeukemiaApproved

Unknown status

Showing 10 of 393 indications

Competition

Competitive Landscape

744 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Decadron

AAspen Global Incorporated

Approved

12 2

Adenocard

Astellas

Preclinical

2 3

Lexiscan

Astellas

Preclinical

1 4

Voltaren

Novartis

Preclinical

1 5

Zolymbus

AbbVie

Preclinical

1 6

Blenoxane

Bristol-Myers Squibb

Preclinical

1 7

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

3 8

Duragesic-100

CCephalon

Preclinical

2 9

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

2 10

Spravato

WWim Janssens

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Post-ApprovalRecruiting

Intraoperative

NCT04182997

Phase 2Recruiting

Lassa Fever

NCT06222723

Phase 1/2Active, not recruiting

Multiple Myeloma

NCT00378105

N/ARecruiting

Dexamethasone Palmitate

NCT06997419

Q1 2027

Phase 1/2Active, not recruiting

Acute Lymphoblastic Leukemia

NCT05192889

Q2 2027

Phase 3Recruiting

Lymphoma

NCT06230224

Clinical

Trials by Indication[1]

Multiple Myeloma50 trials

Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma

Recruiting·MMassachusetts General Hospital·Phase 2·NCT05922501·50 enrolled

Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma

Unknown status·FFred Hutchinson Cancer Center·Phase 2·NCT00438841·43 enrolled

Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study

Active, not recruiting·MMayo Clinic·Phase 1/2·NCT05392946·49 enrolled

Show 47 more trials

Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma

Completed·—·Phase 2·NCT00263484·56 enrolled

Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

Unknown status·—··NCT05495620·300 enrolled

Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma

Completed·EEmory University·Phase 1·NCT01549431·32 enrolled

Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

Completed·VValerio Therapeutics·Phase 2·NCT00131261·25 enrolled

PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Previously Untreated Multiple Myeloma (ELO 1 Substudy)

Terminated· Bristol-Myers Squibb logo

Bristol-Myers Squibb·Phase 3·NCT01891643·23 enrolled

Combination Chemotherapy in Treating Patients With Multiple Myeloma

Completed·NNCIC Clinical Trials Group·Phase 3·NCT00002678·595 enrolled

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Completed·EEastern Cooperative Oncology Group·Phase 3·NCT00002878

Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS

Recruiting·SStichting European Myeloma Network·Phase 2·NCT06189833·200 enrolled

Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Recruiting·—·Phase 1·NCT06348108·32 enrolled

LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma

Completed·WWake Forest University Health Sciences·Phase 1/2·NCT03773107·12 enrolled

A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)

Terminated· Novartis logo

Novartis·Phase 2·NCT02720510·6 enrolled

A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study

Completed· Bristol-Myers Squibb logo

Bristol-Myers Squibb·Phase 3·NCT01311687·455 enrolled

All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma

Active, not recruiting· GSK logo

GSK·Phase 3·NCT06956170·21 enrolled

A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma

Completed· Johnson & Johnson logo

Johnson & Johnson·Phase 3·NCT03234972·213 enrolled

A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Active, not recruiting· Bristol-Myers Squibb logo

Bristol-Myers Squibb·Phase 1·NCT06163898·156 enrolled

THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

Completed·IIRCCS Azienda Ospedaliero-Universitaria di Bologna·Phase 2·NCT01341262·378 enrolled

A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma

Completed·EEmory University·Phase 1·NCT01485835·8 enrolled

Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma

Completed· Johnson & Johnson logo

Johnson & Johnson·Phase 3·NCT02252172·737 enrolled

Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients

Terminated·AAEterna Zentaris·Phase 3·NCT01002248·135 enrolled

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·Phase 3·NCT00075829·710 enrolled

Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure

Completed·UUniversity of Glasgow·Phase 3·NCT00416897·280 enrolled

A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma

Recruiting·GGenrix (Shanghai) Biopharmaceutical Co., Ltd.·Phase 3·NCT07452198·358 enrolled

Combination Chemotherapy in Treating Patients With Multiple Myeloma

Completed·TThe Cleveland Clinic·Phase 2·NCT00003493

Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Terminated·NNantes University Hospital·Phase 2·NCT00337506·50 enrolled

Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Terminated·MMayo Clinic·Phase 1·NCT00687674·13 enrolled

A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Completed· Takeda logo

Takeda·Phase 1/2·NCT01217957·65 enrolled

Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma

Completed· Bristol-Myers Squibb logo

Bristol-Myers Squibb··NCT02692339·22 enrolled

Study of Combination PS-341 and Thalidomide in Multiple Myeloma

Completed·UUniversity of Arkansas·Phase 1·NCT00083460·86 enrolled

Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma

Active, not recruiting·—·Phase 1/2·NCT00378105·68 enrolled

Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)

Active, not recruiting·UUniversity of Leeds·Phase 2·NCT02406222·124 enrolled

Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma

Completed·MMemorial Sloan Kettering Cancer Center·Phase 2·NCT00008242

Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma

Completed· Bristol-Myers Squibb logo

Bristol-Myers Squibb·Phase 1·NCT00555100·15 enrolled

Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma

Completed·EEmory University·Phase 1·NCT03605719·23 enrolled

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma

Completed·UUniversity of Maryland, Baltimore·Phase 2·NCT00003399

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

Completed·AArbeitsgemeinschaft medikamentoese Tumortherapie·Phase 2·NCT02891811·124 enrolled

Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients

Completed· Sanofi logo

Sanofi·Phase 3·NCT02990338·307 enrolled

Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma

Unknown status·RRiverside Haematology Group·Phase 3·NCT00003603·660 enrolled

Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)

Completed·FFondazione EMN Italy Onlus·Phase 2·NCT02206503·13 enrolled

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma

Completed· Bristol-Myers Squibb logo

Bristol-Myers Squibb·Phase 3·NCT01239797·646 enrolled

Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma

Terminated·PPETHEMA Foundation·Phase 1·NCT03023527·6 enrolled

Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma

Terminated·WWeill Medical College of Cornell University·Phase 1·NCT02030483·9 enrolled

Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma

Active, not recruiting·SStichting European Myeloma Network·Phase 3·NCT03710603·709 enrolled

Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma

Completed·MMayo Clinic·Phase 1·NCT03399539·8 enrolled

A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Completed· Amgen logo

Amgen·Phase 3·NCT03859427·454 enrolled

Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

Completed·—·Phase 2·NCT02441686·46 enrolled

Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma

Withdrawn·KKaryopharm Therapeutics Inc·Phase 2·NCT02628704

Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Completed· Bristol-Myers Squibb logo

Bristol-Myers Squibb·Phase 3·NCT01734928·559 enrolled

Dexamethasone13 trials

Exparel v Dexamethasone in RCR

Enrolling by invitation·RRothman Institute Orthopaedics·Phase 4·NCT06575010·126 enrolled

Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and Cyclophosphamide

Completed·UUniversity Hospital Tuebingen·Phase 2·NCT02046915·60 enrolled

Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients After Hip Operations

Completed·GGlostrup University Hospital, Copenhagen·Phase 4·NCT00235261·120 enrolled

Show 10 more trials

Effect of Dexamethasone on Sleep Related Breathing Disturbances in Patients With COPD at Altitude

Completed·UUniversity of Zurich·Phase 4·NCT02450994·124 enrolled

Dexamethasone and Functional Outcome After TKA

Completed·—·Phase 4·NCT05137080·162 enrolled

Long Term Effectiveness of Trigger Finger Injections With Triamcinolone vs. Dexamethasone

Completed·EEricka Lawler·Phase 4·NCT03641508·69 enrolled

The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP

Not yet recruiting·SShandong University·Phase 2/3·NCT06913374·118 enrolled

High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP

Completed·CCooperative Study Group A for Hematology·Phase 3·NCT00451594·157 enrolled

Dexamethasone for the Prophylaxis of Pain Flare Study

Completed·SSunnybrook Health Sciences Centre·Phase 1·NCT00438828·61 enrolled

Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia

Recruiting·RRadboud University Medical Center·Phase 4·NCT06624436·52 enrolled

SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients

Completed· Sanofi logo

Sanofi·Phase 1·NCT01749969·57 enrolled

The Effect of Dexamethasone on Rebound Pain in Patients Receiving Ilioinguinal and Iliohypogastric Nerve Block

Completed·—·N/A·NCT05172908·60 enrolled

Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery

Completed·MMayo Clinic·Phase 4·NCT01450007·130 enrolled

Lymphoma9 trials

Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma

Completed·FFred Hutchinson Cancer Center·Phase 2·NCT00244855·32 enrolled

Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

Completed·UUNICANCER·Phase 3·NCT00003650·179 enrolled

Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Terminated·GGesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH·Phase 1/2·NCT02983097·34 enrolled

Show 6 more trials

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00000658·250 enrolled

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma

Recruiting· Regeneron logo

Regeneron·Phase 3·NCT06230224·216 enrolled

Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma

Completed·UUniversity Hospital, Limoges·Phase 2·NCT00283985·40 enrolled

Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

Completed·MMasonic Cancer Center, University of Minnesota·Phase 2·NCT00005985·213 enrolled

Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma

Completed·UUniversity of Cologne·Phase 2·NCT01569204·100 enrolled

Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma

Terminated·UUniversity of Cologne·Phase 2·NCT00148018·37 enrolled

Acute Lymphoblastic Leukemia7 trials

Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)

Completed·JJapan Adult Leukemia Study Group·Phase 2·NCT00130195·100 enrolled

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Unknown status·JJohann Wolfgang Goethe University Hospital·Phase 2·NCT00199186

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

Unknown status·EEuropean Organisation for Research and Treatment of Cancer - EORTC·Phase 3·NCT00003728·1,500 enrolled

Show 4 more trials

Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia

Terminated·MM.D. Anderson Cancer Center·Phase 2·NCT02420717·11 enrolled

Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

Unknown status·UUniversitätsklinikum Hamburg-Eppendorf·N/A·NCT00343369·550 enrolled

Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Recruiting·IInstitute of Hematology & Blood Diseases Hospital, China·Phase 2·NCT05660473·100 enrolled

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

Active, not recruiting·SSt. Jude Children's Research Hospital·Phase 1/2·NCT05192889·35 enrolled

Nausea and vomiting5 trials

Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Vitrectomy Under Local Anesthesia

Unknown status·UUniversity of Catania·Phase 4·NCT02386059·1,200 enrolled

Aprepitant Versus Gabapentin Prophylaxis for Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgeries

Completed·—·Phase 2/3·NCT02525848·150 enrolled

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Completed·HHeron Therapeutics·Phase 3·NCT00343460·1,428 enrolled

Show 2 more trials

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Completed·AAlliance for Clinical Trials in Oncology·Phase 3·NCT03578081·690 enrolled

Effect of Palonosetron, Ondansetron and Dexamethasone in the Prevention of Postoperative Nausea and Vomiting

Unknown status·SSelcuk University·Phase 3·NCT05439798·66 enrolled

93 more indications

Prostate Cancer4 trials

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Terminated·RRoswell Park Cancer Institute·Phase 2·NCT00524589·18 enrolled

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Active, not recruiting·—·Phase 2·NCT04147806·30 enrolled

Ketoconazole and Dexamethasone in Prostate Cancer

Completed·UUniversity of California, San Francisco·Phase 2·NCT01036594·32 enrolled

Show 1 more trial

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Completed·EEastern Cooperative Oncology Group·Phase 3·NCT00060398·282 enrolled

Tonsillectomy3 trials

Steroids and Pain Control After Tonsillectomy

Completed·MMedical University of South Carolina·Phase 2·NCT03995628·163 enrolled

Prevention of POV After Paediatric Tonsillectomy

Completed·—·Phase 4·NCT02387918·120 enrolled

Dexamethasone for Paediatric Adeno-tonsillectomy - A Dose-finding Study

Terminated·UUniversity Hospital, Geneva·Phase 4·NCT00403806·215 enrolled

Total Knee Arthroplasty3 trials

Dexamethasone Twice for Pain Treatment of Total Knee Arthroplasty

Completed·NNaestved Hospital·Phase 4·NCT03506789·485 enrolled

Effects of Perioperative Intravenous Dexamethasone on the Severity of Persistent Postsurgical Pain After Total Knee Arthroplasty : A Prospective, Randomized, Double-blind, Placebo-controlled Trial

Unknown status·—·Phase 4·NCT02760459·70 enrolled

Single Injection Adductor Canal Block vs Catheter for Total Knee Arthroplasty

Completed·UUniversity of British Columbia·Phase 4·NCT02798835·180 enrolled

COVID-193 trials

RCT on the Efficacy of Dexamethasone Versus Methyl Prednisolone in Covid-19 Infected Patients With High Oxygen Flow

Unknown status·—·Phase 4·NCT05062681·60 enrolled

Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19

Terminated·FFaron Pharmaceuticals Ltd·Phase 2·NCT04860518·7 enrolled

Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19

Unknown status·—·N/A·NCT05279391·150 enrolled

Asthma3 trials

EFFECTIVENESS OF SINGLE DOSE ORAL DEXAMETHASONE VERSUS MULTIDOSE PREDNISOLONE FOR TREATMENT OF ACUTE EXACERBATIONS OF ASTHMA AMONG CHILDREN ATTENDING THE EMERGENCY DEPARTMENT OF CHILDREN HOSPITAL, ISLAMABAD

Unknown status·DDR. MOHAMMAD ALI ARIF·N/A·NCT05850143·192 enrolled

Ideal Steroids for Asthma Treatment in the PICU

Completed·JJohns Hopkins All Children's Hospital·Phase 4·NCT03900624·92 enrolled

Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma

Completed·—·Phase 4·NCT01241006·376 enrolled

Treatment2 trials

PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years

Unknown status·PPETHEMA Foundation·Phase 4·NCT01358201·100 enrolled

Effects of Dry Eye Treatments on the Ocular Surface

Completed·—·Phase 4·NCT01797822·20 enrolled

Immune Thrombocytopenia2 trials

All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Withdrawn·SShandong University·Phase 3·NCT01882127

Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Unknown status·HHospital Universitario Dr. Jose E. Gonzalez·Phase 2·NCT02834286·15 enrolled

Mantle Cell Lymphoma2 trials

Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma

Completed·FFrench Innovative Leukemia Organisation·Phase 2·NCT00740415·39 enrolled

Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

Unknown status·GGerman Low Grade Lymphoma Study Group·Phase 3·NCT00016887

Pain Control2 trials

Preoperative Levator Ani Muscle Injection and Pudendal Nerve Block for Pain Control After Vaginal Reconstructive Surgery

Completed·—·Phase 1/2·NCT03040011·79 enrolled

ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy

Recruiting·UUniversity of Tennessee Medical Center·N/A·NCT05024344·128 enrolled

Hearing Loss2 trials

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

Not yet recruiting·SSeoul National University Hospital·Phase 1/2·NCT06437054·26 enrolled

Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss

Completed·SSeoul National University Hospital·Phase 1/2·NCT04766853·15 enrolled

Carpal Tunnel Syndrome2 trials

Local Injection of Steroid VS.Glucose 5% in Carpal Tunnel Syndrome

Unknown status·—·Phase 4·NCT05496764·52 enrolled

Midazolam Versus Dexamethasone as an Adjuvant to Local Anesthetics in the Ultrasound Guided Hydrodissection of Median Nerve for Treatment of Carpal Tunnel Syndrome Patients

Completed·MMinia University·N/A·NCT04527770·134 enrolled

Amyloidosis2 trials

Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis

Completed·UUniversity Hospital, Limoges·Phase 3·NCT00344526·100 enrolled

Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease

Withdrawn·WWeill Medical College of Cornell University·Phase 1·NCT04984330

Diffuse Large B-Cell Lymphoma2 trials

Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma

Completed· Amgen logo

Amgen·Phase 2·NCT03023878·47 enrolled

A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Terminated· Bristol-Myers Squibb logo

Bristol-Myers Squibb·Phase 2·NCT00474188·26 enrolled

Popliteal Nerve Block2 trials

Efficacy of Popliteal Nerve Blocks With and Without Dexamethasone on the Duration of Analgesia for Foot & Ankle Surgery

Completed·—·Phase 4·NCT01975285·60 enrolled

Dexamethasone vs. Dexmedetomidine for Popliteal Nerve Block in Pain Management After Pediatric Ankle and Foot Surgery

Completed·PPoznan University of Medical Sciences·Phase 4·NCT06233565·90 enrolled

Vomiting2 trials

Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic Laparoscopy

Completed·PPrince of Songkla University·Phase 2·NCT01543945·340 enrolled

Efficacy of Dexamethasone for Prevent Vomiting in Leukemic Children Who Receive Intrathecal Chemotherapy

Completed·CCHANCHAI TRAIVAREE·Phase 4·NCT01094990·32 enrolled

Nausea2 trials

Methylprednisolone vs Dexamethasone: Effects on Sugammadex Reversal, Pain, and Nausea in Adults

Not yet recruiting·KKonya City Hospital·N/A·NCT07187037·130 enrolled

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Completed· GSK logo

GSK·Phase 2·NCT00169572·492 enrolled

Liposomal Bupivacaine2 trials

The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery

Active, not recruiting·SSt. Luke's Hospital, Pennsylvania·Phase 4·NCT06806410·120 enrolled

Liposomal Bupivacaine vs Dexamethasone ISB

Completed·HHospital for Special Surgery, New York·Phase 4·NCT04047446·112 enrolled

Calcification1 trial

Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)

Terminated·UUniversidad Peruana Cayetano Heredia·Phase 2/3·NCT02945527·4 enrolled

Pilot Study1 trial

Comparison of Outcomes of Management of Bowel Obstruction Pilot Study

Enrolling by invitation·UUniversity of Washington·Phase 4·NCT06817551·10 enrolled

Outcome1 trial

Comparison of Outcomes of Management of Bowel Obstruction

Recruiting·UUniversity of Washington·Phase 4·NCT07084441·550 enrolled

Pregnant Women1 trial

A Clinical Pharmacological Study of Dose Halving of Dexamethasone in Pregnant Women With Preterm Labour With Preterm Birth at Greater Than or Equal to 34 Gestational Weeks (34GW+)

Not yet recruiting·PPeking University Third Hospital·N/A·NCT06350565·48 enrolled

Analgesic Efficacy1 trial

Analgesic Efficacy of Perineural Dexamethasone During Supraclavicular Block for Hand Surgery

Terminated·—·Phase 2·NCT02154048·5 enrolled

Chronic Obstructive Pulmonary Disease1 trial

Dexamethasone Versus Prednisone in Heart Failure Patients, Hospitalized With Exacerbation of Chronic Obstructive Pulmonary Disease.

Unknown status·RRabin Medical Center·Phase 4·NCT02237820·80 enrolled

Thrombocytopenia1 trial

Thrombocytopenia in Gestational Period

Unknown status·PPeking University People's Hospital·Phase 2/3·NCT02751593·70 enrolled

Preterm Delivery1 trial

The Effect of Zinc, β-carotene, and Vitamin D3 in Preterm Delivery Through Placental MyD88, TRIF, NFkB, and IL-1β

Completed·IIndonesia University·Phase 4·NCT03005496·56 enrolled

Arthroscopic Shoulder Surgery1 trial

Intravenous Dexmedetomidine, Dexamethasone and Interscalene Block Duration After Arthroscopic Shoulder Surgery

Completed·UUniversity of Manitoba·Phase 4·NCT03270033·198 enrolled

Myeloma1 trial

A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma

Unknown status·PPeter MacCallum Cancer Centre, Australia·Phase 1/2·NCT00431990·40 enrolled

Acetaminophen1 trial

Antagonism Research Between Antiemetics Agents and Acetaminophen in Thyroidectomy's Post-operative Analgesia.

Completed·UUniversity Hospital, Lille·Phase 3·NCT01679093·66 enrolled

Peripheral Blood Stem Cell Transplantation1 trial

Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation

Completed·WWashington University School of Medicine·Phase 1·NCT00314743·48 enrolled

Efficacy and Safety1 trial

Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS

Recruiting·PPeking Union Medical College Hospital·N/A·NCT06387823·300 enrolled

Peripheral Nerve Block1 trial

Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair

Completed·—·Phase 4·NCT04737980·92 enrolled

Randomized1 trial

A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP

Unknown status·SShandong University·Phase 4·NCT04094805·60 enrolled

Malignant Mesothelioma1 trial

Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma

Terminated·NNational Cancer Institute (NCI)·Phase 1·NCT04840615·2 enrolled

Dysphagia1 trial

Effect of Local Intraoperative Steroid on Dysphagia After ACDF

Completed·RRush University Medical Center·Phase 3·NCT03311425·140 enrolled

Quality of Recovery1 trial

Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration

Completed·PPontificia Universidade Catolica de Sao Paulo·Phase 4·NCT03035942·135 enrolled

Lenalidomide1 trial

Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet

Completed· Amgen logo

Amgen·Phase 2·NCT04191616·54 enrolled

Breast Cancer1 trial

Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients

Terminated·SS. Maria Hospital, Terni·Phase 3·NCT00869973·580 enrolled

Glioblastoma1 trial

Function and Composition of Regulatory B Cells in Participants With Glioblastoma

Terminated·AAmsterdam UMC, location VUmc··NCT04128774·5 enrolled

Total Hip Arthroplasty1 trial

Dexamethasone in Total Knee and Total Hip Arthroplasty

Unknown status·UUniversity Health Network, Toronto·Phase 2/3·NCT02760043·314 enrolled

Epstein Barr Virus1 trial

Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes

Completed·—·Phase 2·NCT00953420·20 enrolled

Post Operative Sore Throat1 trial

Comparison of the Effect of Magnesium Sulfate and Dexamethasone on Postoperative Sore Throat After Spinal Surgery in Prone Position With Tracheal Intubation: a Double-blind, Randomized, Noninferiority Clinical Trial

Completed·YYonsei University·N/A·NCT01923831·146 enrolled

Malnutrition1 trial

Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer

Completed·—·N/A·NCT03263520·60 enrolled

Postoperative Analgesia1 trial

Comparison Between Bupivacaine and Bupivacaine- Dexamethasone QLB for Postoperative Analgesia

Completed·—·Phase 1·NCT05918796·60 enrolled

Age-Related Macular Degeneration1 trial

Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself

Withdrawn·VVitreous -Retina- Macula Consultants of New York·Phase 2·NCT00457678

Inflammatory Bowel Disease1 trial

Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease

Terminated·UUniversity of Chicago·N/A·NCT00152620·40 enrolled

Dexamethasone Palmitate1 trial

Dexamethasone Palmitate for PONV After Open Surgery

Recruiting·—·N/A·NCT06997419·500 enrolled

Ovarian Hyperstimulation Syndrome1 trial

Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome

Unknown status·SSun Yat-sen University·Phase 2·NCT02846493·200 enrolled

Anaplastic Large Cell Lymphoma1 trial

Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99)

Completed·GGustave Roussy, Cancer Campus, Grand Paris·Phase 3·NCT00006455·885 enrolled

Axillary Nerve Block1 trial

Dexamethasone as Adjuvant to Bupivacaine in Suprazygomatic Maxillary Nerve Block

Unknown status·—·N/A·NCT05530811·34 enrolled

Kidney Transplant1 trial

Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

Completed·JJohns Hopkins University·Phase 3·NCT00275509·56 enrolled

Hematoma1 trial

Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma

Terminated·UUniversity of Virginia·Phase 2/3·NCT02111785·10 enrolled

Pharyngitis1 trial

Inhaled Steroids for Acute Pharyngitis.

Completed·OOman Medical Speciality Board·Phase 2/3·NCT04027322·200 enrolled

Temporomandibular Disorders1 trial

Management of Temporomandibular Disorders (TMD)

Completed·MMinia University·N/A·NCT06759584·80 enrolled

Jaundice1 trial

The Effects of Dexamethasone Administration on Jaundice Following Liver Resection

Completed·SShanghai Zhongshan Hospital·Phase 2/3·NCT02991339·76 enrolled

Precursor B-Cell Acute Lymphoblastic Leukemia1 trial

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

Completed·SSt. Jude Children's Research Hospital·Phase 2·NCT01700946·80 enrolled

Cataract1 trial

Effectiveness of Periocular Drug Injection in CATaract Surgery

Terminated·LLuigi Rondas·Phase 3·NCT05158699·628 enrolled

Erector Spinae Plane Block1 trial

Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery

Completed·HHospital for Special Surgery, New York·Phase 4·NCT04156581·46 enrolled

Dexamethasone Administration1 trial

Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role?

Completed·TThe Cleveland Clinic·Phase 2·NCT03338400·51 enrolled

Surgical Wound Infection1 trial

The Effects of Hypercapnia, Supplemental Oxygen, and Dexamethasone on Surgical Wound Infection

Completed·TThe Cleveland Clinic·Phase 3·NCT00273377·2,000 enrolled

Sudden Sensorineural Hearing Loss1 trial

High Dose Oral Steroids in Sudden Sensorineural Hearing Loss

Withdrawn·UUniversity of Colorado, Denver·Phase 2·NCT03255473

Keratoconjunctivitis1 trial

Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda

Completed·UUniversity Hospital, Ghent·Phase 4·NCT01211327·366 enrolled

Adult Acute Lymphoblastic Leukemia1 trial

Treatment of High Risk Adult Acute Lymphoblastic Leukemia

Completed·PPETHEMA Foundation·Phase 4·NCT00853008·100 enrolled

Respiratory Disease1 trial

Completed·UUniversity of Zurich·Phase 4·NCT02450968·124 enrolled

Crohn's Disease1 trial

Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease

Terminated·QQuince Therapeutics S.p.A.·Phase 3·NCT01277289·51 enrolled

Leukemia1 trial

Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Completed·MMemorial Sloan Kettering Cancer Center·Phase 2·NCT00002471

Dexmedetomidine1 trial

Dexamethasone Versus Dexmedetomidine as Adjuvants for Nerve Blocks

Completed·UUniversity of Chile·N/A·NCT03610893·120 enrolled

Hyperglycemia1 trial

Intraoperative Dexamethasone and Its Effect on Hyperglycemia

Withdrawn·AAscension Health·Phase 4·NCT03646916

Dermatitis1 trial

Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis

Unknown status·AAzidus Brasil·Phase 3·NCT01239719·96 enrolled

T-cell acute lymphoblastic leukemia1 trial

Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)

Withdrawn·NNational Cancer Institute (NCI)·Phase 2·NCT06210750

Glaucoma1 trial

Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents

Completed·GGlaukos Corporation·Phase 4·NCT02873806·53 enrolled

Lassa fever1 trial

LAssa Fever Adjunct Treatment With DEXamethasone

Recruiting·BBernhard Nocht Institute for Tropical Medicine·Phase 2·NCT06222723·42 enrolled

Newly Diagnosed1 trial

Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM

Completed·—·Phase 2·NCT02375555·40 enrolled

Intraoperative1 trial

Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy

Recruiting·UUniversity of Missouri-Columbia·Phase 4·NCT04182997·200 enrolled

Healing1 trial

Effect of Honey and Dexamethason on Extraction Healing

Completed·—·Phase 1·NCT04848259·80 enrolled

AL amyloidosis1 trial

Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis

Completed·NNanjing University School of Medicine·Phase 3·NCT01998503·56 enrolled

Posterior Uveitis1 trial

A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Completed· AbbVie logo

AbbVie·Phase 2/3·NCT00333814·229 enrolled

Chronic Lymphocytic Leukemia1 trial

Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia

Completed·GGerman CLL Study Group·Phase 2·NCT00276809·30 enrolled

Mortality1 trial

Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, with CoViD-19

Completed·HHôpital NOVO·Phase 3·NCT04765371·89 enrolled

Enhanced Recovery1 trial

Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data

Completed·JJennifer Holder-Murray·Phase 3·NCT04606264·2,977 enrolled

Surgical1 trial

Steroid-induced Reduction of Surgical Stress Study

Withdrawn·AAmsterdam UMC, location VUmc·N/A·NCT00807521

B-cell acute lymphoblastic leukemia1 trial

Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Completed·SSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University·Phase 1·NCT03472573·7 enrolled

Knee Arthroscopic Surgery1 trial

Analgesia in Knee Arthroscopic Surgery

Completed·—·Phase 2·NCT02818985·60 enrolled

Completed·—·Phase 2·NCT00250926·23 enrolled

Post Operative Pain1 trial

Ultrasound Guided Bilateral Superficial Cervical Block for Post-operative Pain Therapy in Thyroid Surgery

Unknown status·—·N/A·NCT03109691·60 enrolled

Plasma Cell Leukemia1 trial

Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia

Completed·MMayo Clinic·Phase 2·NCT02547662·17 enrolled

Pulmonary Fibrosis1 trial

Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab

Unknown status·QQingdao Central Hospital·Phase 2·NCT01917877·30 enrolled

Cardiac Surgery1 trial

Dexamethasone for Cardiac Surgery Trial

Completed·UUMC Utrecht·N/A·NCT00293592·4,500 enrolled

Adductor Canal Block1 trial

Analgesic Effect of Adductor Canal Block With and Without Dexamethasone for Knee Arthroscopy

Completed·—·N/A·NCT03239314·60 enrolled

Serratus Anterior Plane Block1 trial

Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block

Not yet recruiting·—·Phase 4·NCT06300099·126 enrolled

Postimplantation Syndrome1 trial

Effect of Dexamethason on Postimplantation Syndrome After EVAR

Not yet recruiting·—·Phase 4·NCT06044480·158 enrolled

Unspecified1 trial

Blood and Marrow Transplant Clinical Research Network

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·N/A·NCT00023530

Regulatory

FDA Approval Timeline[5]

Jan 1, 1982

DECADRON

NDA NDA012376

Jan 1, 1982

HEXADROL

NDA NDA012674

Jan 1, 1982

DECADERM

NDA NDA013538

Jan 1, 1982

DECADRON

NDA NDA012071

Jan 1, 1982

DECADRON-LA

NDA NDA016675

Jan 1, 1982

HEXADROL

NDA NDA014694

Jan 1, 1982

DECADRON

NDA NDA011977

Jan 1, 1982

DECADRON

NDA NDA011984

Jan 1, 1982

MAXIDEX

NDA NDA013422

Jan 1, 1982

DECADRON

NDA NDA011664

Jan 1, 1982

DEXACORT

NDA NDA013413

Jan 1, 1982

HEXADROL

NDA NDA012675

Jan 1, 1982

DEXACORT

NDA NDA014242

Jan 1, 1982

DECASPRAY

NDA NDA012731

Jan 1, 1982

DECADRON

NDA NDA011983

Jun 17, 2009

OZURDEX

NDA NDA022315

Feb 9, 2018

DEXYCU KIT

NDA NDA208912

Nov 30, 2018

DEXTENZA

NDA NDA208742

Oct 3, 2019

HEMADY

NDA NDA211379

Sources

References

[1]
ClinicalTrials.gov — 2317 trial records for dexamethasone. U.S. National Library of Medicine, National Institutes of Health.
[2]
MedlinePlus Drug Information — Decadron drug information. U.S. National Library of Medicine, National Institutes of Health.
[3]
ChEMBL — dexamethasone compound record. European Bioinformatics Institute (EMBL-EBI).
[4]
Open Targets Platform — Drug–disease associations for dexamethasone. EMBL-EBI & Wellcome Sanger Institute.
[5]
OpenFDA — FDA approval records (NDA NDA211379). U.S. Food & Drug Administration.
[6]
FDA Orange Book — Patent and exclusivity data for Decadron. U.S. Food & Drug Administration.
[7]
SEC EDGAR — Aspen Global Incorporated company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Mechanism of Action: Glucocorticoid Receptor Agonist[3]
Modality: Small molecule[3]
Highest Phase: Approved[1]
Company: AAspen Global Incorporated

Patent Landscape[6]

Patent Cliff

Feb 12, 2030

Earliest patent expiration — generic entry possible after this date

Patent #Expires

8563027Feb 12, 2030

8409606May 14, 2030

10799642May 11, 2032

10028965May 23, 2034

10159683May 23, 2034

7 more patents

10022502Jun 22, 2034

12150896Oct 7, 2036

11458041Nov 16, 2037

11304961Dec 18, 2037

10537585Dec 18, 2037

11097061Jun 23, 2039

12144889Apr 26, 2041